Log In
Print this Print this

Oral CR845

Also known as: CR845

  Manage Alerts
Collapse Summary General Information
Company Cara Therapeutics Inc.
DescriptionLong-acting peripheral kappa opioid receptor (OPRK1; KOR) agonist
Molecular Target Kappa opioid receptor (KOR) (OPRK1)
Mechanism of ActionKappa opioid receptor agonist
Therapeutic ModalityPeptide

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today